Vectura Group PLC (LON:VEC) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $82.18 and traded as low as $82.00. Vectura Group shares last traded at $83.00, with a volume of 384,147 shares traded.
Several analysts have issued reports on VEC shares. Citigroup restated a “buy” rating on shares of Vectura Group in a research report on Thursday, November 7th. Shore Capital restated a “hold” rating on shares of Vectura Group in a research report on Wednesday, November 27th. Finally, Peel Hunt restated a “hold” rating on shares of Vectura Group in a research report on Wednesday, November 27th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of GBX 133.50 ($1.74).
The company has a debt-to-equity ratio of 1.73, a quick ratio of 2.41 and a current ratio of 2.84. The company has a market capitalization of $507.15 million and a price-to-earnings ratio of -6.48. The firm’s 50-day simple moving average is GBX 84.97 and its 200-day simple moving average is GBX 82.18.
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta and Anoro Ellipta for the treatment of COPD.
Featured Article: How can you know how many shares are floating?
Receive News & Ratings for Vectura Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group and related companies with MarketBeat.com's FREE daily email newsletter.